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Abstract
Background: During erythrocytic schizogony, Plasmodium falciparum interacts with the human
erythrocyte membrane when it enters into, grows within and escapes from the erythrocyte. An
interaction between the P. falciparum M18 aspartyl aminopeptidase (PfM18AAP) and the human
erythrocyte membrane protein spectrin was recently identified using phage display technology. In
this study, recombinant (r) PfM18AAP was characterized and the interaction between the enzyme
and spectrin, as well as other erythrocyte membrane proteins, analyzed.
Methods:  rPfM18AAP was produced as a hexahistidine-fusion protein in Escherichia coli and
purified using magnetic bead technology. The pI of the enzyme was determined by two-dimensional
gel electrophoresis and the number of subunits in the native enzyme was estimated from Ferguson
plots. The enzymatic activity over a pH and temperature range was tested by a coupled enzyme
assay. Blot overlays were performed to validate the spectrin-PfM18AAP interaction, as well as
identify additional interactions between the enzyme and other erythrocyte membrane proteins.
Sequence analysis identified conserved amino acids that are expected to be involved in cofactor
binding, substrate cleavage and quaternary structure stabilization.
Results: rPfM18AAP has a molecular weight of ~67 kDa and the enzyme separated as three
entities with pI 6.6, 6.7 and 6.9. Non-denaturing gel electrophoresis indicated that rPfM18AAP
aggregated into oligomers. An in vitro coupled enzyme assay showed that rPfM18AAP cleaved an
N-terminal aspartate from a tripeptide substrate with maximum enzymatic activity at pH 7.5 and
37°C. The spectrin-binding region of PfM18AAP is not found in Homo sapiens, Saccharomyces
cerevisiae  and otherPlasmodium  species homologues. Amino acids expected to be involved in
cofactor binding, substrate cleavage and quaternary structure stabilization, are conserved. Blot
overlays with rPfM18AAP against spectrin and erythrocyte membrane proteins indicated that
rPfM18AAP binds to spectrin, as well as to protein 4.1, protein 4.2, actin and glyceraldehyde 3-
phosphate dehydrogenase.
Conclusion:  Studies characterizing rPfM18AAP showed that this enzyme interacts with
erythrocyte spectrin and other membrane proteins. This suggests that, in addition to its proposed
role in hemoglobin digestion, PfM18AAP performs other functions in the erythrocyte host and can
utilize several substrates, which highlights the multifunctional role of malaria enzymes.
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Background
Malaria, caused by an Apicomplexan of the genus Plasmo-
dium, is one of the most prevalent and lethal diseases
affecting the human race. Yearly 300–660 million people
are diagnosed with clinical malaria [1] and the World
Health Organization estimates that annually 2.7 million
deaths are attributed to this disease [2]. The highest inci-
dence of malaria, especially the severest form of malaria,
caused by Plasmodium falciparum, occurs in Africa [1].
After transmission to humans, P. falciparum spends the
disease-causing stage of its life cycle in erythrocytes. Entry
into the erythrocyte, parasite growth and escape from the
host cell all require protein-protein interactions between
the parasite and the human erythrocyte membrane, which
makes the study of these interactions a key issue in
malaria research.
The erythrocyte membrane skeleton is located just
beneath the erythrocyte membrane and consists of a two-
dimensional network of spectrin tetramers linked to junc-
tional complexes. Spectrin tetramers are the predominant
proteins in the membrane skeleton and consist of two
supercoiled rope-like spectrin-heterodimers which self-
associate to form the tetramer. Each heterodimer contains
an alpha and beta spectrin chain composed of multiple
homologous 106 amino acid residue motifs (termed spec-
trin repeats) which fold into triple alpha-helical bundles
[3]. Spectrin tetramers are long flexible molecules in the
lattice framework that lend stability and flexibility to the
membrane skeleton and are responsible for maintaining
the shape of the erythron. Junctional complexes are
located at the distal end of the spectrin tetramer, where
the N-termini of six beta spectrin chains link to two actin
protofilaments via protein 4.1 and dematin [3].
The malaria parasite initiates invasion by interacting with
the glycophorins and band 3 that are exposed on the
erythrocyte membrane surface. Several parasite ligands,
for example, merozoite surface protein 1 (MSP-1) [4],
MSP-9 [5], erythrocyte binding antigen 175 (EBA-175) [6]
and EBA-140 [7] have been shown to interact with eryth-
rocyte receptors, and some ligands, such as MSP-1, also
interact with the spectrin molecules lying beneath the
membrane [8]. Other parasite proteins, such as serine-rich
antigen (SERA), the rhoptry proteins [9], ring-infected
erythrocyte surface antigen (RESA), and gp76 [10] induce
structural changes in the erythrocyte membrane phos-
pholipids and the underlying membrane skeleton, which
allow the parasite to enter the erythrocyte. Of these pro-
teins, RESA has been shown to interact with spectrin by
acting as a chaperone during the repair of the membrane
skeleton after invasion has been completed. The protein
binds to beta spectrin, close to the self-association site
where it stabilizes the spectrin tetramer, thereby increas-
ing the thermostability of the erythrocyte and preventing
further invasion by other malaria parasites [11].
During parasite growth, striking structural and morpho-
logical changes are induced in the host cell. These include
the loss of the typical erythrocyte shape, alterations in the
mechanical properties of the cell, and modifications of
the phosphorylation state of erythrocyte membrane skel-
eton proteins. Knobs, which play a role in sequestration,
are also introduced on the host cell surface. Numerous
parasite proteins, for example, P. falciparum erythrocyte
membrane protein 3 (PfEMP-3), mature parasite-infected
surface antigen (MESA), falciparum-exported serine/threo-
nine kinase (FEST), and falciparum  interspersed repeat
antigen (FIRA), are associated with the membrane skele-
ton [12]. Knob-associated histidine-rich protein (KAHRP)
and PfEMP-1 are present in the knobs, which interact with
erythrocyte membrane skeleton proteins, such as spectrin,
protein 4.1 and actin [12]. For example, MESA binds to
protein 4.1 [13] and KAHRP interacts with repeat 4 on
alpha spectrin [14], as well as the phosphorylated band 3-
binding domain of ankyrin [15]. The cytoplasmic domain
of PfEMP-1 also binds to the spectrin-actin junction of the
membrane skeleton [16].
The release of the parasite from its host cell also depends
on parasite-erythrocyte membrane interactions and sev-
eral parasite enzymes have been suggested to play roles in
the breakdown of the erythrocyte membrane skeleton. For
example, a 37 kDa acidic protease cleaves beta spectrin
and protein 4.1 [17]. Plasmepsin-II, which has a primary
role in hemoglobin digestion, cleaves the SH3 domain of
alpha spectrin at a neutral pH, and also interacts with
actin and protein 4.1 [18]. Another food vacuole enzyme,
the cysteine protease falcipain-2, cleaves ankyrin and pro-
tein 4.1 within the spectrin-actin-binding domain [19].
Previous work from our laboratory, which involved bio-
panning a P. falciparum phage-display library against
erythrocyte spectrin, revealed that a 33 amino acid pep-
tide of PfM18AAP interacts with the erythrocyte mem-
brane skeleton [20]. In this study the biochemical
characteristics of the full length rPfM18AAP were evalu-
ated and the protein-protein interactions between
rPfM18AAP and spectrin, as well as other erythrocyte
membrane proteins, were investigated.
Methods
Sequence analysis of PfM18AAP
Aspartyl aminopeptidase proteases from H. sapiens
(Q9ULAO), S. cerevisiae (P38821), Plasmodium falciparum
(PFI1570c),  Plasmodium chabaudi chabaudi
(PC000238.00.0),  Plasmodium yoelii yoelii (PY03205),
Plasmodium knowlesi (PKH_073050), and Plasmodium
vivax (Pv087090) were retrieved from the NCBI and Plas-Malaria Journal 2008, 7:161 http://www.malariajournal.com/content/7/1/161
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moDB (version 5.3) database. The sequences were aligned
using ClustalW at EMBL-EBI http://www.ebi.ac.uk/Tools/
clustalw/index.html.
Preparation of rPfM18AAP
Plasmodium falciparum was cultured in vitro by the method
of Trager and Jensen [21] and genomic DNA extracted by
first lysing the erythrocytes and subsequently boiling the
parasites to release the DNA [22]. The PfM18AAP
sequence (nucleotides 7–1689 of gene PFI1570c taken
from the PlasmoDB (version 5.3) database) was amplified
from the parasite DNA by PCR, using sequence specific
primers containing 5' NdeI and 3'BamHI recognition
sequences (restriction enzyme recognition sequence is in
bold; F: 5' CTGAGGAACTGCATATGAAGAAAGCTAG-
GGAATACGCC 3'; R: 5' TGTGCTGGATCCTCATAA-
GACTTGGTTGATGTAGG 3'). The amplified DNA was
inserted into the pET15-b vector (Novagen, USA), the
insert sequenced and BL21-CodonPlus® (DE3) RIL com-
petent cells (Stratagene, USA) were transformed with the
vector construct. rPfM18AAP, containing an N-terminal
hexahistidine-tag, was produced in Overnight Express™
Instant TB Medium (Novagen, USA) and purified from E.
coli  extracts using HIS-Select™ Magnetic Agarose Beads
(Sigma, USA). The rPfM18AAP concentration was deter-
mined spectrophotometrically at 595 nm using the
Coomassie Plus® Protein Assay Reagent Kit (Pierce, USA)
and the purified protein sample analyzed by sodium
dodecylsulphate 10% polyacrylamide gel electrophoresis
(SDS-PAGE) [23].
PfM18AAP isoelectric point and native oligomeric state 
determination
The hexahistidine-tag was removed from rPfM18AAP with
the THROMBIN CleanCleave™ KIT (Sigma, USA) and the
isoelectric point (pI) of rPfM18AAP determined by two-
dimensional gel electrophoresis [24] against 2-D SDS-
PAGE Standards (Bio-Rad, USA). The first dimension iso-
electric focusing (IEF) gel contained the Bio-Lyte® 3/10
Ampholyte (Bio-Rad, USA) and the second dimension
Laemmli SDS-polyacrylamide gel [23] contained 13% acr-
ylamide. The proteins were visualized by silver staining.
The number of subunits of native rPfM18AAP was deter-
mined by Ferguson plots [25]. The protein was electro-
phoresed through non-denaturing agarose-acrylamide
tube gels containing 3, 4, 5, 6, 7, 8, 9, and 10% acrylamide
and 0.3% agarose [26]. The approximate molecular
weight of each rPfM18AAP subunit was determined from
a standard curve constructed from the relative mobility of
bovine serum albumin (BSA) (monomer = 66 kDa; dimer
= 132 kDa) and human erythrocyte spectrin (dimer = 460
kDa; tetramer = 920 kDa; hexamer = 1380 kDa). Tube gels
were cut in half to facilitate transfer onto Hybond™-C
Extra Nitrocellulose membrane (Amersham, UK) and the
rPfM18AAP detected with 1:2000 Penta·His™ HRP Con-
jugate antibody (Qiagen, Germany) using the SuperSig-
nal®  West Pico Chemiluminescent Substrate (Pierce,
USA).
rPfM18AAP enzyme assay
A coupled enzyme assay using 0.3 mM Asp-Ala-Pro-beta-
Napthylamide (Peptides International, USA) and 0.0025
U dipeptidyl peptidase IV (Sigma, USA) in 50 mM Tris-
HCl (pH 7.5) was used to study the enzymatic activity of
2.5 μg rPfM18AAP in a final volume of 50 μl [27]. To
determine the optimum pH, the enzyme assay was per-
formed with 50 mM Tris-HCl buffer at pH 6.8, 7.5, 8.0,
8.5 and 9.0, or 0.1 M sodium citrate buffer at pH 5.3, 6.0
and 6.5. A temperature study was completed in 50 mM
Tris-HCl buffer (pH 7.5) at 25, 30, 33, 37 and 39°C.
Blot overlay assays
Blot overlay assays were used to confirm the interaction
between rPfM18AAP and erythrocyte spectrin, as well as
to study the protein-protein interactions between
rPfM18AAP and other erythrocyte membrane proteins.
Approximately 1 μg spectrin tetramers and dimers [28],
100 ng rPfM18AAP (positive control) and 100 ng BSA
(negative control) were applied to a Hybond™-C Extra
Nitrocellulose membrane in a Bio-Rad Bio-Dot® SF cham-
ber (Bio-Rad, USA). To test the interaction of rPfM18AAP
with other erythrocyte membrane proteins, 100 ng
rPfM18AAP (positive control), 100 ng BSA (negative con-
trol) and 20 μg erythrocyte membrane proteins [28] were
electrophoresed through a Laemmli SDS 9% polyacryla-
mide gel [23] or a Fairbanks SDS 3.5–17.5% polyacryla-
mide gel [29,30] and transferred onto a Hybond™-C Extra
Nitrocellulose membrane. Membranes were blocked with
5% BSA in TBS (10 mM Tris-HCl, 150 mM NaCl, pH 7.5)
and subsequently overlaid for 1 hr at room temperature
with 1.25–2.5 μg rPfM18AAP in either 50 mM Tris-HCl
(pH 7.5), or 50 mM Tris-HCl (pH 7.5) containing 150
mM NaCl. Membranes were washed four times for 10
minutes in wash buffer (20 mM Tris-HCl, 500 mM NaCl,
0.12% Tween®-20 (v/v), 0.2% Triton® X-100 (v/v), pH 7.5)
and once for 10 minutes in TBS. The membranes were
fixed for 20 minutes with 0.5% (v/v) formaldehyde fol-
lowed by a 10 minute wash with TBS. The presence of
rPfM18AAP was detected with 1:2000 Penta·His™ HRP
Conjugate antibody using the SuperSignal®  West Pico
Chemiluminescent Substrate.
Results and Discussion
Analysis of the PfM18AAP protein sequence and spectrin-
binding region
PfM18AAP is classified as an M18 aminopeptidase in the
MEROPS database [31]. The 33 amino acid spectrin-bind-
ing region of PfM18AAP, which was initially identified byMalaria Journal 2008, 7:161 http://www.malariajournal.com/content/7/1/161
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phage display [20], was not found in the H. sapiens or S.
cerevisiae sequences (Additional File 1). This region may
represent a special evolutionary adaptation of P. falci-
parum, since it is specific for PfM18AAP and is not found
in other Plasmodium species. Despite this species-specific
spectrin-binding insert, there is a 64–74% sequence iden-
tity between PfM18AAP and the Plasmodium homologues.
The sequence probably forms a loop on the surface of the
active enzyme [32] and could, therefore, allow PfM18AAP
to bind to spectrin, without interfering with the enzymatic
function.
PfM18AAP is a metalloprotease and requires cofactors,
probably cobalt [32], for enzymatic activity. These cofac-
tors are bound by specific amino acids that are present in
all the M18 aminopeptidases (Additional File 1). Con-
served amino acids are labeled according to the amino
acid numbers of the human aspartyl aminopeptidase [33]
and the amino acid numbers of PfM18AAP are given in
brackets. The five amino acids, H94, D264, E302, D346
and H440 (H86, D324, E380, D434 and H534) involved
in cofactor binding [31], as well as the two amino acids,
D96 and E301 (D88 and E379) involved in substrate
cleavage [31] are conserved in PfM18AAP. Two additional
histidines, H170 (H160), involved in enzymatic activity
[33] and H352 (H440), involved in quaternary structure
stabilization [33], are also present in all the sequences
(Additional File 1).
Biochemical characterization of rPfM18AAP
Only a small proportion of rPfM18AAP was expressed as
soluble protein after induction in Overnight Express™
Instant TB Medium and therefore only ~1 μg of soluble
protein was obtained from a one liter E. coli culture. The
N-terminal hexahistidine-tag present in rPfM18AAP was
detected by Western blot analysis (Figure 1) and purifica-
tion of rPfM18AAP from E. coli extracts yielded a protein
sample of more than 85% purity as determined by scan-
ning densitometry. The rPfM18AAP sample generally con-
tained low molecular weight contaminants (Figure 1).
SDS-polyacrylamide gels indicated that rPfM18AAP
migrated at ~67 kDa (Figure 1), which approximates the
calculated molecular weight (66.9 kDa) of the recom-
binant protein.
rPfM18AAP minus the hexahistidine-tag (~65 kDa) sepa-
rated as three entities with pI 6.6, 6.7 and 6.9 during iso-
electric focusing (data not shown). Electrophoresis
through non-denaturing gels (Figure 2) and Ferguson plot
analysis (Additional file 2) showed that the rPfM18AAP
occurred mainly as a monomer, tetramer and higher oli-
gomeric forms. The rPfM18AAP dimer was present in very
small amounts. Western blot analysis confirmed that the
lower protein band was the rPfM18AAP monomer and
that the upper smear included the dimer and tetramer
(Figure 2). The smear extended past the tetramer to the
top of the gels indicating that there were higher oligo-
meric forms (e.g. octamer and dodecamer) of rPfM18AAP
Affinity purification of rPfM18AAP Figure 1
Affinity purification of rPfM18AAP. SDS-polyacrylamide gel (left) and immunoblot (right) showing the purification of 
rPfM18AAP. Lane M – erythrocyte membrane proteins; W – induced E. coli whole cell extract; S – soluble protein fraction after 
cell lysis; Ub – protein fraction that did not bind to the HIS-Select™ Magnetic Agarose Beads; 1–5 – consecutive 20 mM imida-
zole washes; E – 200 mM imidazole elution of rPfM18AAP.
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present. The lower bands seen on the non-denaturing gels
were not detected during Western blot analysis with the
PentaHis™ HRP Conjugate antibody, indicating that these
proteins were contaminants isolated during the purifica-
tion procedure. Teuscher et al showed that recombinant
PfM18AAP occurred as an octamer in its active native state
by assaying HPLC fractions for enzymatic activity [32].
This is the same number of subunits as the human aspar-
tyl aminopeptidase [27]. However, the unpublished crys-
tal structures of Clostridium acetobutylicum,  Thermotoga
maritima, and Pseudomonas aeruginosa M18 proteases (Pro-
tein Data Bank: http://www.rcsb.org/pdb/home/
home.do), showed that these enzymes occur as dodecam-
ers. To resolve the issue of the subunit composition of the
native PfM18AAP, crystallization of the enzyme will be
required.
Enzyme activity assays showed that rPfM18AAP cleaves
the N-terminal aspartate from the tripeptide Asp-Ala-Pro-
beta-Napthylamide. Teuscher et al showed that
rPfM18AAP also cleaves dipeptides and that the enzyme is
more active on N-terminal glutamates in comparison to
N-terminal aspartates [32]. Both these amino acids are
acidic indicating that PfM18AAP cleaves peptides and pro-
teins that have an acidic N-terminal amino acid.
A pH study showed that rPfM18AAP is active from pH 6.8
to 8.5 (Figure 3), with the highest activity at the physio-
logical pH of 7.5 and no great difference in enzyme activ-
ity between pH 7.3–7.7. The enzyme had no activity at pH
5.3, which is close to the pH of the food vacuole (5.0–5.2
[34]). The parasite uses the food vacuole for the digestion
of hemoglobin into 2–10 amino acid peptides [35,36],
which are subsequently exported into the parasite cytosol
where they are converted into amino acids by PfM18AAP
and other aminopeptidases [32,36]. The parasite cytosol
has a pH of 7.3–7.4 [37], allowing PfM18AAP to be active
in this parasite compartment. Even though PfM18AAP has
no export signals, it has been localized to the parasitopho-
rous vacuole by immunoblot analysis [32] and the eryth-
rocyte membrane by mass spectroscopy [38]. The enzyme
could, therefore, also be active in the erythrocyte cytosol
which has a neutral pH of 7.2–7.3 [39].
A temperature study revealed that rPfM18AAP is func-
tional from 33–39°C with maximum enzymatic activity
at 37°C (Figure 3), which indicates that the enzyme is
active when the parasite resides in the human host.
rPfM18AAP has 90% enzymatic activity at 39°C (Figure
3), indicating that the enzyme is still functional when the
human host experiences fever (maximum temperature
42°C), which occurs after the erythrocytes rupture [40].
PfM18AAP could therefore be active during invasion and
growth in new erythrocytes.
rPfM18AAP binds to spectrin and other erythrocyte 
membrane skeleton proteins
Blot overlay assays with rPfM18AAP against spectrin (Fig-
ure 4) and erythrocyte membrane proteins (Figure 5) con-
firmed our phage display results, which showed an
interaction between spectrin and a 33 amino acid peptide
of PfM18AAP [20]. The anti-His6 antibody does not inter-
act with any of the erythrocyte membrane proteins as
shown in Figure 1 lane 1 and Additional file 3. Beta spec-
trin showed much stronger binding to rPfM18AAP than
alpha spectrin (Figure 5 and Fairbanks SDS-PAGE, data
not shown), which explains why there is no signal evident
for alpha spectrin in figure 5A. rPfM18AAP also reacted
with other erythrocyte membrane proteins, including pro-
tein 4.1, protein 4.2, actin and glyceraldehyde 3-phos-
phate dehydrogenase (G3PD) (Figure 5). In addition,
performing the overlay under isotonic conditions (Figure
5B) increased binding to all the target erythrocyte mem-
brane proteins.
Actin and alpha spectrin could be prime targets for
PfM18AAP, because they have three aspartates (actin) and
one glutamate (alpha-spectrin) after the N-terminal
methionine, which would be cleaved from newly synthe-
sized proteins by the human methionine aminopepti-
dases [41]. Beta spectrin, protein 4.1 and protein 4.2
contain either an aspartate or a glutamate [32] close to
their N-termini. These acidic residues could potentially
become available after cleavage of the preceding amino
Non-denaturing electrophoresis of rPfM18AAP Figure 2
Non-denaturing electrophoresis of rPfM18AAP. Non-
denaturing agarose/polyacrylamide gels (left) and immunoblot 
(right) showing the monomer and tetramer of rPfM18AAP. 
The protein was electrophoresed through non-denaturing 
gels containing 5, 6, 7, and 8% acrylamide. rPfM18AAP was 
detected with the PentaHis™ HRP Conjugate antibody.
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acids by endogenous proteases. Alternatively, another sce-
nario may also be possible. The 33 amino acid binding
region of PfM18AAP is on the surface of the enzyme and
is not implicated in the catalytic site, which raises the
interesting possibility that the enzyme could bind to a
protein, but not necessarily cleave it. This could be the
case with proteins that do not have an appropriate acidic
residue at the N terminus. These proteins could be used as
anchors and the enzyme could cleave proteins situated
adjacent to it on the membrane, which consists of a net-
work of interacting proteins.
Actin and protein 4.1 are located in the junctional com-
plexes and protein 4.2 is located in the band 3 complex of
the erythrocyte membrane [3]. The N-termini of beta spec-
trin molecules are linked to actin and protein 4.1 in the
junctional complex and the N-termini of alpha spectrin
are located at the self-association sites of spectrin tetram-
ers [3]. Cleavage of any of these proteins could therefore
destabilize and disrupt the junctional complexes, the
band 3 complexes and the spectrin tetramers.
Function of PfM18AAP in the infected erythrocyte
The presumed primary function of PfM18AAP in P. falci-
parum is to cleave aspartates or glutamates from the oli-
gopeptides that are exported from the food vacuole into
the parasite cytosol after hemoglobin digestion [32,36].
Amino acids are released from the cell and this regulates
the colloid-osmotic pressure within the infected erythro-
cyte to prevent premature cell lysis and to establish a con-
centration gradient that facilitates the entry of rare amino
Relative enzymatic activity of rPfM18AAP over a pH and temperature range Figure 3
Relative enzymatic activity of rPfM18AAP over a pH and temperature range. Graphs showing the relative activity 
(%) of rPfM18AAP over a pH (left) and temperature (right) range. The pH range included pH values of the parasite food vacu-
ole (pH 5.0–5.4), the parasite cytosol (pH 7.3–7.4) and the erythrocyte cytosol (pH 7.2–7.3). The temperature range was cho-
sen to cover the temperature within the mosquito (26°C) and the human erythrocyte during normal (37°C) and fever (39°C) 
conditions.
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Blot overlay assay of rPfM18AAP and human erythrocyte  spectrin Figure 4
Blot overlay assay of rPfM18AAP and human eryth-
rocyte spectrin. Slot blots containing spectrin dimers and 
tetramers overlaid with rPfM18AAP (+) and Tris buffer (pH 
7.5) (-). Slot A1 – rPfM18AAP (positive control); A2 – bovine 
serum albumin (negative control); B1 – spectrin dimers; B2 – 
spectrin tetramers. rPfM18AAP was detected with 1:2000 
Penta·His™ HRP Conjugate antibody using the SuperSignal® 
West Pico Chemiluminescent Substrate.
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acids into the infected erythrocyte [42]. PfM18AAP may
therefore be indirectly involved in regulating the volume
of the host cell to accommodate the increasing size of the
growing parasite.
Our studies, as well as PfM18AAP mRNA and protein data
from other laboratories, indicate that the enzyme could
also perform additional functions in the parasitophorous
vacuole, the erythrocyte cytosol and particularly at the
infected erythrocyte membrane skeleton. Microarray data
showed that PfM18AAP mRNA is expressed throughout
the erythrocytic stages, with the highest expression levels
in early and late trophozoites and in gametocytes [43],
whilst Northern blot analysis revealed predominant
expression in rings [32]. Protein data localized PfM18AAP
in merozoites, trophozoites, schizonts [44] and at the
infected erythrocyte membrane in trophozoite/schizont
stage parasites [38]. Western blot analysis, utilizing anti-
PfM18AAP antiserum, also revealed the enzyme in rings,
the parasite cytosol and the parasitophorous vacuole [32].
PfM18AAP mRNA is therefore transcribed into the active
enzyme at several stages in the erythrocytic life cycle and
the PfM18AAP protein is located in several compartments
within the parasite-infected erythrocyte. These data imply
that  PfM18AAP could play a role in parasite invasion,
growth and exit from the host cell, since parasite proteins
interact with the erythrocyte membrane and the underly-
ing erythrocyte membrane skeleton during intracellular
development.
Merozoites are the invasive form of the parasite in eryth-
rocytic schizogony and utilize proteases to gain entry into
the new host cell. Inhibition studies with 1,10-phenan-
throline have shown that metalloproteases are involved in
parasite invasion [45] and hence PfM18AAP could be
involved in this process. During invasion and early
growth of the parasite, the host experiences febrile parox-
ysms triggered by the release of toxins during parasitized
Blot overlay assay of rPfM18AAP and erythrocyte membrane proteins Figure 5
Blot overlay assay of rPfM18AAP and erythrocyte membrane proteins. Blot overlay assays were performed four 
times under hypotonic (A) and isotonic (B) conditions and illustrate the interaction between rPfM18AAP and erythrocyte 
membrane skeleton proteins. Blot overlays are in the left panels of each figure and the Laemmli SDS-polyacrylamide gels are on 
the right. A. In the absence of salt, and using a short exposure time of 5 minutes for the chemiluminescence reaction, 
rPfM18AAP binds to beta spectrin, protein 4.1, protein 4.2, actin and G3PD (lane 3 on the immunoblot). Lane 1 – rPfM18AAP 
(positive control); lane 2 – bovine serum albumin (negative control); lane 3 – erythrocyte membrane proteins. B. In the pres-
ence of a physiological salt concentration, lane 2 on the blot overlay on the left depicts a short exposure (5 minutes) and shows 
that rPfM18AAP binds strongly to alpha spectrin, beta spectrin and G3PD. The reaction with beta spectrin is more intense than 
with alpha spectrin. Lane 2 on the middle blot overlay depicts a longer exposure (20 minutes) and shows that rPfM18AAP also 
binds to protein 4.1, protein 4.2 and actin. Lane 1 – rPfM18AAP (positive control); lane 2 – erythrocyte membrane proteins.
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erythrocyte rupture [40]. Since PfM18AAP is functional at
elevated temperatures, we speculate that it may be respon-
sible for regulating, processing and activating other para-
site proteins within the ring stage by removing their N-
termini.
Several parasite proteases, such as plasmepsin-II [18] and
falcipain-2 [19], which are primarily involved in hemo-
globin digestion inside the food vacuole, also facilitate the
release of the parasite from its erythrocytic host by cleav-
ing membrane skeleton proteins such as spectrin. Studies
with inhibitors have proven that parasite proteases first
weaken the parasitophorous vacuole membrane and then
the erythrocyte membrane prior to parasite release [46],
which is caused by an osmotic pressure build-up within
the erythrocyte [47]. Weakening of the erythrocyte mem-
brane would involve the disruption of the spectrin-junc-
tional complex network below the plasma membrane.
Given that PfM18AAP is located in the parasitophorous
vacuole [32] and at the erythrocyte membrane [38], and
that the enzyme binds to several erythrocyte membrane
proteins and functions at neutral pH, it is, therefore, plau-
sible that PfM18AAP could also play a role in the release
of the parasite from its erythrocyte host.
PfM18AAP may represent a novel drug target, since knock-
down experiments utilizing a plasmid containing an anti-
sense copy of the PFI1570c gene, resulted in a lethal
phenotype [32]. A knockout experiment utilizing a single-
crossover strategy [36] produced a truncated PfDAP
(PfM18AAP), which retained ~10% enzymatic activity
when compared to wild-type parasites. This did not have
deleterious effects on parasite replication, possibly
because the small amount of active PfM18AAP was suffi-
cient to perform the appropriate enzymatic reactions in
the parasite. Additional evidence is thus required to vali-
date PfM18AAP as a drug target. If the enzyme is essential
for parasite survival, the development of PfM18AAP
inhibitors could lead to new drugs that can be employed
to fight malaria infections.
Conclusion
PfM18AAP binds to erythrocyte spectrin and other eryth-
rocyte membrane proteins. Our evidence and that from
other laboratories, suggest that PfM18AAP performs mul-
tiple enzymatic functions in the parasite and the erythro-
cytic host, particularly at the erythrocyte membrane
skeleton. These include the final step in hemoglobin
digestion, as well as additional roles in erythrocyte inva-
sion, parasite growth and parasite escape from the host
cell. These data highlight the multifunctional role of
malaria proteases.
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Additional File 1
ClustalW alignment of PfM18AAP with Homo sapiens, Saccharo-
myces cerevisiae, and other Plasmodium homologues. The 
sequences, H. sapiens (Hs) (Q9ULAO), S. cerevisiae (Sc) (P38821), 
P. falciparum (Pf) (PFI1570c), P. chabaudi chabaudi (Pc) 
(PC000238.00.0), P. yoelii yoelii (Py) (PY03205), P. knowlesi (Pk) 
(PKH_073050), and P. vivax (Pv) (Pv087090)) were aligned using the 
ClustalW program. The five amino acids (blue) that bind the co-factor 
and the two amino acids (red) that cleave the substrate are conserved 
amongst all the species. An additional histidine (yellow) involved in enzy-
matic activity and another histidine (green) involved in quaternary struc-
ture stabilization are also marked. The 33 amino acid spectrin-binding 
region (orange) is only present in the P. falciparum aspartyl aminopepti-
dase.
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rPfM18AAP. Lane 1 – bovine serum albumin; lane 2 – rPfM18AAP 
(positive control); lane 3 – erythrocyte membrane proteins.
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